Anti-IL-17 agents show impressive clinical, histological, and transcriptional resolution of psoriasis, while anti-TNF-α agents can induce paradoxical psoriasis in patients with autoimmune diseases other than psoriasis38,39. This evidence concerns the gene IL17A and psoriasis.